These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 37548863)

  • 1. Clinical and magnetic resonance imaging spectrum of complex perianal fistulizing Crohn's disease: A cohort study from northern India.
    Singh A; Kakkar C; Garg S; Arora K; Midha V; Mahajan R; Virk SS; Jain NP; Singh D; Sood K; Tripathi A; Gupta D; Kaushal IG; Galhotra RD; Saggar K; Sood A
    Indian J Gastroenterol; 2023 Oct; 42(5):668-676. PubMed ID: 37548863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Infliximab on Deep Radiological Remission in Chinese Patients with Perianal Fistulizing Crohn's Disease.
    Zhu M; Xu X; Feng Q; Cui Z; Wang T; Yan Y; Ran Z
    Dig Dis Sci; 2021 May; 66(5):1658-1668. PubMed ID: 32524415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
    Bouguen G; Siproudhis L; Gizard E; Wallenhorst T; Billioud V; Bretagne JF; Bigard MA; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the modified Van Assche index for assessing response to anti-TNF therapy with MRI in perianal fistulizing Crohn's disease.
    van Rijn KL; Lansdorp CA; Tielbeek JAW; Nio CY; Buskens CJ; D'Haens GRAM; Löwenberg M; Stoker J
    Clin Imaging; 2020 Feb; 59(2):179-187. PubMed ID: 31821976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of pelvic MRI in assesment of combined surgical and infliximab treatment for perianal Crohn's disease.
    Gligorijević V; Spasić N; Bojić D; Protić M; Svorcan P; Maksimovic B; Marković V; Krivokapić Z; Jojić Nj
    Acta Chir Iugosl; 2010; 57(3):89-95. PubMed ID: 21066991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and MRI Evolution After Local Injection of Bone Marrow-Derived Mesenchymal Stem Cells in Perianal Fistulae in Crohn's Disease: Results From a Prospective Monocentric Study.
    Reenaers C; Gillard RP; Coimbra C; Gillard RM; Meunier P; Lechanteur C; Baudoux E; Boutaffala L; Beguin Y; Louis É
    J Crohns Colitis; 2023 May; 17(5):728-737. PubMed ID: 36733215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging may predict deep remission in patients with perianal fistulizing Crohn's disease.
    Thomassin L; Armengol-Debeir L; Charpentier C; Bridoux V; Koning E; Savoye G; Savoye-Collet C
    World J Gastroenterol; 2017 Jun; 23(23):4285-4292. PubMed ID: 28694669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical advantages of combined seton placement and infliximab maintenance therapy for perianal fistulizing Crohn's disease: when and how were the seton drains removed?
    Tanaka S; Matsuo K; Sasaki T; Nakano M; Sakai K; Beppu R; Yamashita Y; Maeda K; Aoyagi K
    Hepatogastroenterology; 2010; 57(97):3-7. PubMed ID: 20422862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn's perianal fistulas.
    Schwartz DA; White CM; Wise PE; Herline AJ
    Inflamm Bowel Dis; 2005 Aug; 11(8):727-32. PubMed ID: 16043987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience.
    Topstad DR; Panaccione R; Heine JA; Johnson DR; MacLean AR; Buie WD
    Dis Colon Rectum; 2003 May; 46(5):577-83. PubMed ID: 12792431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which magnetic resonance imaging feature is associated with treatment response in perianal fistulizing Crohn's disease?
    Richard N; Derinck A; Bridoux V; Charpentier C; Savoye Collet C; Savoye G
    Abdom Radiol (NY); 2024 Aug; 49(8):2913-2920. PubMed ID: 38512515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of infliximab combined with surgery for perianal fistulizing Crohn's disease.
    Yang BL; Chen YG; Gu YF; Chen HJ; Sun GD; Zhu P; Shao WJ
    World J Gastroenterol; 2015 Feb; 21(8):2475-82. PubMed ID: 25741157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and treatment of perianal fistulising Crohn's disease in Colombia: Results of a multicentric registry.
    Juliao-Baños F; Osorio L; Carvajal J; Mosquera-Klinger G; Medellín A; Padrón J; de Molano B; Puentes F; Muñoz E; Reyes G; Gil F; Parra-Izquierdo V; Sánchez H
    Gastroenterol Hepatol; 2022 Nov; 45(9):690-696. PubMed ID: 35278506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes in perianal fistulizing Crohn's disease in a resource-limited setting: A cohort analysis.
    Vuyyuru SK; Sahu P; Kedia S; Kante B; Kumar P; Ranjan MK; Sharma R; Makharia G; Gupta SD; Sahni P; Ahuja V
    Indian J Gastroenterol; 2020 Oct; 39(5):435-444. PubMed ID: 33040321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of adalimumab therapy in multidisciplinary strategy for perianal Crohn's disease patients with infliximab failure.
    Echarri A; Castro J; Barreiro M; Carpio D; Pereira S; Lorenzo A
    J Crohns Colitis; 2010 Dec; 4(6):654-60. PubMed ID: 21122576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perianal complete remission with combined therapy (seton placement and anti-TNF agents) in Crohn's disease: a Brazilian multicenter observational study.
    Kotze PG; Albuquerque IC; da Luz Moreira A; Tonini WB; Olandoski M; Coy CS
    Arq Gastroenterol; 2014; 51(4):284-9. PubMed ID: 25591155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement.
    Regueiro M; Mardini H
    Inflamm Bowel Dis; 2003 Mar; 9(2):98-103. PubMed ID: 12769443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrosis and MAGNIFI-CD Activity Index at Magnetic Resonance Imaging to Predict Treatment Outcome in Perianal Fistulizing Crohn's Disease Patients.
    van Rijn KL; Meima-van Praag EM; Bossuyt PM; D'Haens GR; Gecse KB; Horsthuis K; Snijder HJ; Tielbeek JAW; Buskens CJ; Stoker J
    J Crohns Colitis; 2022 Jun; 16(5):708-716. PubMed ID: 34644395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fistulizing perianal Crohn's disease: contrast-enhanced magnetic resonance imaging assessment at 1 year on maintenance anti-TNF-alpha therapy.
    Savoye-Collet C; Savoye G; Koning E; Dacher JN; Lerebours E
    Inflamm Bowel Dis; 2011 Aug; 17(8):1751-8. PubMed ID: 21744430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic ultrasound for perianal Crohn's disease: disease and fistula characteristics, and impact on therapy.
    Lahat A; Assulin Y; Beer-Gabel M; Chowers Y
    J Crohns Colitis; 2012 Apr; 6(3):311-6. PubMed ID: 22405167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.